Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin Sattentau

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nature Reviews. Microbiology|October 17, 2008
Avoiding the void: cell-to-cell spread of human virusesQuentin Sattentau
Current Opinion in HIV and AIDS|April 18, 2009
Correlates of antibody-mediated protection against HIV infectionQuentin Sattentau
The Journal of Clinical Investigation|September 3, 2004
Dangerous liaisons at the virological synapseVincent Piguet, Quentin Sattentau
Expert Reviews in Molecular Medicine|February 16, 2005
The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?Neil Sheppard, Quentin Sattentau
Current Opinion in HIV and AIDS|April 3, 2009
Cell-to-cell HIV-1 spread and its implications for immune evasionNicola Martin, Quentin Sattentau
Current Drug Targets. Infectious Disorders|June 25, 2005
Fundamental immunology and what it can teach us about HIV vaccine developmentN Avrion Mitchison, Quentin Sattentau
Journal of Virology|November 12, 2003
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamersMakobetsa Khati, Michael Schüman, Jamal Ibrahim, et al.
Frontiers in Immunology|April 21, 2022
Vaccine-Associated Enhanced Disease and Pathogenic Human CoronavirusesCillian Gartlan, Tom Tipton, Francisco J Salguero, et al.
Molecular Cell|May 8, 2018
RNA Helicase DDX1 Converts RNA G-Quadruplex Structures into R-Loops to Promote IgH Class Switch RecombinationClaudia Ribeiro de Almeida, Somdutta Dhir, Ashish Dhir, et al.
Vaccine|December 15, 2010
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigenMauricio A Arias, Andrew Loxley, Christy Eatmon, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nature Reviews. Microbiology|October 17, 2008
Avoiding the void: cell-to-cell spread of human virusesQuentin Sattentau
Current Opinion in HIV and AIDS|April 18, 2009
Correlates of antibody-mediated protection against HIV infectionQuentin Sattentau
The Journal of Clinical Investigation|September 3, 2004
Dangerous liaisons at the virological synapseVincent Piguet, Quentin Sattentau
Expert Reviews in Molecular Medicine|February 16, 2005
The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?Neil Sheppard, Quentin Sattentau
Current Opinion in HIV and AIDS|April 3, 2009
Cell-to-cell HIV-1 spread and its implications for immune evasionNicola Martin, Quentin Sattentau
Current Drug Targets. Infectious Disorders|June 25, 2005
Fundamental immunology and what it can teach us about HIV vaccine developmentN Avrion Mitchison, Quentin Sattentau
Journal of Virology|November 12, 2003
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamersMakobetsa Khati, Michael Schüman, Jamal Ibrahim, et al.
Frontiers in Immunology|April 21, 2022
Vaccine-Associated Enhanced Disease and Pathogenic Human CoronavirusesCillian Gartlan, Tom Tipton, Francisco J Salguero, et al.
Molecular Cell|May 8, 2018
RNA Helicase DDX1 Converts RNA G-Quadruplex Structures into R-Loops to Promote IgH Class Switch RecombinationClaudia Ribeiro de Almeida, Somdutta Dhir, Ashish Dhir, et al.
Vaccine|December 15, 2010
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigenMauricio A Arias, Andrew Loxley, Christy Eatmon, et al.
Pageof 3